Table 5.
Temporal Trends in Clinical Outcomes
| 2008 | 2010 | 2013 | 2016 | P Trend | |
|---|---|---|---|---|---|
| Entire cohort | |||||
| n | 1716 | 1720 | 1665 | 1724 | |
| 30‐d MACE | 215 (12.5) | 173 (10.1) | 176 (10.6) | 151 (8.8) | 0.001 |
| 30‐d mortality | 72 (4.2) | 68 (4.0) | 61 (3.7) | 51 (3.0) | 0.05 |
| 1‐y mortality | 135 (8.0) | 133 (7.8) | 136 (8.3) | 131 (7.7) | 0.9 |
| Low risk | |||||
| n | 641 | 599 | 569 | 609 | |
| 30‐d MACE | 41 (6.4) | 36 (6.0) | 46 (8.1) | 50 (8.2) | 0.11 |
| 30‐d mortality | 7 (1.1) | 4 (0.7) | 6 (1.1) | 9 (1.5) | 0.4 |
| 1‐y mortality | 8 (1.3) | 9 (1.5) | 14 (2.5) | 14 (2.3) | 0.1 |
| Intermediate risk | |||||
| n | 433 | 462 | 437 | 458 | |
| 30‐d MACE | 39 (9.0) | 36 (7.8) | 40 (9.2) | 32 (7.0) | 0.4 |
| 30‐d mortality | 8 (1.9) | 8 (1.7) | 10 (2.3) | 9 (2.0) | 0.7 |
| 1‐y mortality | 17 (4.0) | 20 (4.4) | 24 (5.6) | 20 (4.5) | 0.5 |
| High risk | |||||
| n | 642 | 659 | 659 | 657 | |
| 30‐d MACE | 135 (21.0) | 101 (15.3) | 90 (13.7) | 69 (10.5) | <0.001 |
| 30‐d mortality | 57 (8.9) | 56 (8.5) | 45 (6.9) | 33 (5.0) | 0.004 |
| 1‐y mortality | 110 (17.2) | 104 (15.8) | 98 (15.1) | 97 (15.0) | 0.2 |
Values are presented as n (%). MACE includes death, unstable angina pectoris, myocardial infarction, cerebrovascular accident, stent thrombosis, and urgent revascularization. MACE indicates major adverse cardiac events.